Cargando…
Optimization of anti-ADAMTS13 antibodies for the treatment of ADAMTS13-related bleeding disorder in patients receiving circulatory assist device support
ADAMTS13 (a disintegrin-like and metalloproteinase with thrombospondin type-1 motif 13)-related bleeding disorder has been frequently observed as a life-threatening clinical complication in patients carrying a circulatory assist device. Currently, treatment modalities for the bleeding disorder are v...
Autores principales: | Ito, Toshihiro, Minamitani, Takeharu, Hayakawa, Masaki, Otsubo, Ryota, Akiba, Hiroki, Tsumoto, Kouhei, Matsumoto, Masanori, Yasui, Teruhito |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8595387/ https://www.ncbi.nlm.nih.gov/pubmed/34785706 http://dx.doi.org/10.1038/s41598-021-01696-3 |
Ejemplares similares
-
Novel neutralizing human monoclonal antibodies against tetanus neurotoxin
por: Minamitani, Takeharu, et al.
Publicado: (2021) -
Determination of ADAMTS13 and Its Clinical Significance for ADAMTS13 Supplementation Therapy to Improve the Survival of Patients with Decompensated Liver Cirrhosis
por: Uemura, Masahito, et al.
Publicado: (2011) -
ADAMTS‐13 and bleeding phenotype in von Willebrand disease
por: Boender, Johan, et al.
Publicado: (2020) -
ADAMTS13 and Non-ADAMTS13 Biomarkers in Immune-Mediated Thrombotic Thrombocytopenic Purpura
por: Bonnez, Quintijn, et al.
Publicado: (2023) -
ADAMTS13, TTP and Beyond
por: Zheng, X Long
Publicado: (2012)